These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35814972)

  • 1. Today's Mistakes and Tomorrow's Wisdom… in the Management of T1b Barrett's Adenocarcinoma.
    Chan MW; Nieuwenhuis EA; Pouw RE
    Visc Med; 2022 Jun; 38(3):196-202. PubMed ID: 35814972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
    Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
    Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma.
    Künzli HT; Belghazi K; Pouw RE; Meijer SL; Seldenrijk CA; Weusten B; Bergman J
    United European Gastroenterol J; 2018 Jun; 6(5):669-677. PubMed ID: 30083328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
    Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
    Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Today's Mistakes and Tomorrow's Wisdom in the Surgical Treatment of Barrett's Adenocarcinoma.
    Garbarino GM; van Berge Henegouwen MI; Gisbertz SS; Eshuis WJ
    Visc Med; 2022 Jun; 38(3):203-211. PubMed ID: 35814974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Submucosal invasion and risk of lymph node invasion in early Barrett's cancer: potential impact of different classification systems on patient management.
    Fotis D; Doukas M; Wijnhoven BP; Didden P; Biermann K; Bruno MJ; Koch AD
    United European Gastroenterol J; 2015 Dec; 3(6):505-13. PubMed ID: 26668743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
    Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
    Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of T1b esophageal adenocarcinoma patients.
    Tian J; Prasad GA; Lutzke LS; Lewis JT; Wang KK
    Gastrointest Endosc; 2011 Dec; 74(6):1201-6. PubMed ID: 22000793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green.
    Overwater A; Weusten BLAM; Ruurda JP; van Hillegersberg R; Bennink RJ; de Keizer B; Meijer SL; Brosens LAA; Pouw RE; Bergman JJGHM; van Berge Henegouwen MI; Gisbertz SS
    Surg Endosc; 2022 Apr; 36(4):2671-2679. PubMed ID: 34046715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.
    Sgourakis G; Gockel I; Lang H
    World J Gastroenterol; 2013 Mar; 19(9):1424-37. PubMed ID: 23539431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma?
    Ramay FH; Vareedayah AA; Visrodia K; Iyer PG; Wang KK; Eluri S; Shaheen NJ; Reddy R; Martin LW; Greenwald BD; Edwards MA
    Ann Surg Oncol; 2019 Mar; 26(3):714-731. PubMed ID: 30607765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Today's Mistakes and Tomorrow's Wisdom in Endoscopic Treatment and Follow-Up of Barrett's Esophagus.
    Barret M
    Visc Med; 2022 Jun; 38(3):189-195. PubMed ID: 35814978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience.
    Graham D; Sever N; Magee C; Waddingham W; Banks M; Sweis R; Al-Yousuf H; Mitchison M; Alzoubaidi D; Rodriguez-Justo M; Lovat L; Novelli M; Jansen M; Haidry R
    World J Gastroenterol; 2018 Nov; 24(41):4698-4707. PubMed ID: 30416317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Today's Mistakes and Tomorrow's Wisdom in Endoscopic Imaging of Barrett's Esophagus.
    van Heijst LE; Zhao X; Gabriëls RY; Nagengast WB
    Visc Med; 2022 Jun; 38(3):182-188. PubMed ID: 35814977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection.
    Probst A; Aust D; Märkl B; Anthuber M; Messmann H
    Endoscopy; 2015 Feb; 47(2):113-21. PubMed ID: 25479563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma.
    Leggett CL; Lewis JT; Wu TT; Schleck CD; Zinsmeister AR; Dunagan KT; Lutzke LS; Wang KK; Iyer PG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):658-64.e1-3. PubMed ID: 25151255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and Safety of Tailored Lymphadenectomy Using Sentinel Node-Navigated Surgery in Patients with High-Risk T1 Esophageal Adenocarcinoma.
    Frederiks CN; Overwater A; Bergman JJGHM; Pouw RE; de Keizer B; Bennink RJ; Brosens LAA; Meijer SL; van Hillegersberg R; van Berge Henegouwen MI; Ruurda JP; Gisbertz SS; Weusten BLAM
    Ann Surg Oncol; 2023 Jul; 30(7):4002-4011. PubMed ID: 36959491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extending treatment criteria for Barrett's neoplasia: results of a nationwide cohort of 138 endoscopic submucosal dissection procedures.
    van Munster SN; Verheij EPD; Nieuwenhuis EA; Offerhaus JGJA; Meijer SL; Brosens LAA; Weusten BLAM; Alkhalaf A; Schenk EBE; Schoon EJ; Curvers WL; van Tilburg L; van de Ven SEM; Tang TJ; Nagengast WB; Houben MHMG; Seldenrijk KCA; Bergman JJGHM; Koch AD; Pouw RE;
    Endoscopy; 2022 Jun; 54(6):531-541. PubMed ID: 34592769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection.
    Ballard DD; Choksi N; Lin J; Choi EY; Elmunzer BJ; Appelman H; Rex DK; Fatima H; Kessler W; DeWitt JM
    World J Gastrointest Endosc; 2016 Dec; 8(20):763-769. PubMed ID: 28042390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.